Search Results
Mar 05, 2026, 09:31 ET NuScale Power Corporation (SMR) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Robbins Geller Rudman & Dowd LLP
Mar 05, 2026, 09:15 ET Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
our partners' ability to deploy new products, services, and applications, and to expand the markets for genomics-related products and services; and (iii) the challenges associated with multiparty collaborations, including our reliance on the performance of such partners, together with other factors detailed
More news about: Illumina, Inc.
Mar 05, 2026, 08:52 ET PLUG CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Plug Power Investors of Securities Class Action Deadline on April 3, 2026
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.On October 7, 2025, Plug Power issued
More news about: Faruqi & Faruqi, LLP
Mar 05, 2026, 08:38 ET New York Road Runners Names Learning Ally as Official Charity Partner of the 2026 TCS New York City Marathon
literacy gap in this iconic marathon is a meaningful reflection of our New York roots and our enduring commitment to educational equity," said Howard Bell III, CEO of Learning Ally."New York Road Runners is honored to welcome Learning Ally team to the 2026 TCS New York City Marathon as they raise
More news about: Learning Ally
Mar 05, 2026, 08:30 ET SIRIUSXM ANNOUNCES EXPIRATION AND RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING 3.125% SENIOR NOTES DUE 2026
obligations, in such amounts as would be sufficient to pay the principal of and interest on, the Notes to the redemption date or the maturity date, or (iii) pursue any combination of the foregoing. This press release does not constitute a notice of redemption or an offer to purchase the Notes not purchased
More news about: Sirius XM Holdings Inc.
Mar 05, 2026, 08:29 ET 일루미나, TruPath Genome 출시 및 NovaSeq X 로드맵 공개… Connected Multiomics로 암 연구 혁신 가속
주는 주요 요소로는 (i) 적시에 비용 효율적으로 NovaSeq X 업데이트를 수행할 수 있는 당사의 역량; (ii) 제조 운영 확장 또는 변경, 핵심 부품에 대한 제3자 공급업체에의 의존 등 새로운 제품, 서비스 및 기술의 연구, 개발 및 출시에 내재된 난관; (iii) 견고한 장비 및 소모품을 제조하고 신뢰성 있는 소프트웨어 솔루션을 개발할 수 있는 당사의 역량; (iv) 당사와 고객의 기대에 부합하거나 이에 못 미치는 당사가 신규 출시 또는 업데이트한 제품의 고객 수용 및 채택; (v) 새로운 제품, 서비스 및 애플리케이션을 배포하고 유전체 관련 제품 및 서비스 시장을 확대하는
More news about: Illumina
Mar 05, 2026, 08:22 ET イルミナ、TruPath Genomeを発表、NovaSeq Xロードマップを公開、Connected Multiomicsでがん研究のブレークスルーを推進
合があります。実際の結果が将来の見通しに関する記述の結果と大きく異なり当社の事業に影響する重要な要因には、次のものがあります:(i) NovaSeq Xシステムのアップデートを費用対効果が高くタイムリーに実施する当社の能力。(ii) 新製品・サービス・技術の研究開発・導入に伴う固有の課題（製造プロセスの変更・拡張を含む）および重要部品の外部調達への依存。(iii) 堅牢な装置・消耗品の製造能力ならびに信頼性の高いソフトウェアソリューションの開発能力。(iv) 新規・更新製品の顧客による受容・採用（当社及び顧客の期待に沿うか否かは不確実）。(v) 新製品・サービス・アプリケーションの導入、ならび
More news about: Illumina
Mar 05, 2026, 08:00 ET Origis Energy Announces $545 Million Financing for Texas Solar Portfolio
multi-project solar complex in West Texas, which will total over 700 MW upon completion. The complex also includes the Swift Air Solar II and Swift Air Solar III projects, which reached financial close in 2025.The senior secured credit facilities include construction loan, term loan, tax credit bridge,
More news about: Origis Energy
Mar 05, 2026, 07:05 ET REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
activating U.S. clinical sites in the pivotal Phase IIb/III NAAVIGATE study. The Company will receive a $100 million milestone payment from AbbVie upon first patient dosed in the Phase IIb portion, expected Q2 2026.NAAVIGATE is a Phase IIb/III multicenter, randomized, masked, sham-controlled study
More news about: REGENXBIO Inc.
Mar 05, 2026, 07:00 ET Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
Evogene, including, the aftermath of the recent war between Israel and each of (i) the terrorist groups, Hamas and Hezbollah, (ii) Iran, and (iii) other regional terrorist groups supported by Iran, and any destabilizations in Israel, neighboring territories or the Middle East region, as well as
More news about: Evogene
Mar 05, 2026, 06:10 ET Best Collagen for Women (2026): California Gold Nutrition CollagenUP Named Leading Formula for Skin and Joint Support by Consumer365
also matters. Marine collagen, derived from fish, is typically rich in Type I collagen, the predominant type found in skin. Some formulas include Type III collagen, which supports connective tissue and structural integrity.Effective collagen supplements often include supportive nutrients. Vitamin
More news about: Consumer365.org
Mar 05, 2026, 06:00 ET Maple Leaf Foods Reports Fourth Quarter and Full Year 2025 Financial Results
(iii) Not meaningful.Fourth Quarter 2025Sales
More news about: Maple Leaf Foods Inc.
Mar 05, 2026, 03:30 ET TORM plc - Notice of and Complete Proposals for the Annual General Meeting 2026
Copenhagen and Nasdaq in New York, and Computershare DR Nominees Limited for A-shares not traded on those markets and held beneficially by OCM Njord, and (iii) the Bank being entitled to act as agent for the Company under Buyback Contract B. Details of the price and number of A-shares to be purchased pursuant
More news about: Torm PLC
Mar 04, 2026, 23:15 ET CAIXA: LUCRO LÍQUIDO RECORRENTE DE R$ 15,5 BILHÕES EM 2025, CRESCIMENTO DE 10,4% EM RELAÇÃO A 2024.
III. ROE recorrente alcança 10,7% em Dez25,
More news about: CAIXA
Mar 04, 2026, 23:10 ET CAIXA: RECURRING NET INCOME OF R$15.5 BILLION IN 2025, REPRESENTING YEAR-OVER-YEAR GROWTH OF 10.4%
III. Recurring ROE reached 10.7%
More news about: CAIXA
Mar 04, 2026, 21:26 ET Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
recurrent/metastatic cervical cancer. It is under evaluation in 11 registrational/Phase III studies across major first-line tumor indications, various cold tumors, and IO-resistant settings, including a global Phase III trial in first-line gastric cancer and a global registrational trial in IO-resistant
More news about: Akeso, Inc.
Mar 04, 2026, 17:46 ET H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
efficacy in H. pylori infection, emerging as a potential first-in-class, purpose-designed therapy in a field with little innovation for decades. Phase III trials reported eradication rates >90%, demonstrating superiority or non-inferiority to bismuth-based quadruple therapy, including in antibiotic-resistant
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 16:30 ET ASUR Calls for a Shareholders' Meeting
Market Law; proposal and, if applicable, approval of the provisions and policies regarding the repurchase of Company shares. Resolutions thereon.III. Ratification, if applicable, of the administration by the Board of Directors and the Chief Executive Officer for the fiscal year of 2025 and appointment
More news about: Grupo Aeroportuario del Sureste S.A.B. de C.V.
Mar 04, 2026, 16:15 ET Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - RGRD Law
Ultragenyx' Phase III Orbit study would fail to achieve a statistically significant reduction in annualized fracture rate ("AFR"), such that the second interim analysis could be performed and presented to the investing public; and (ii) in truth, Ultragenyx' optimism in the Phase III Orbit study's results
More news about: Robbins Geller Rudman & Dowd LLP
Mar 04, 2026, 16:05 ET CRACKER BARREL REPORTS SECOND QUARTER FISCAL 2026 RESULTS AND UPDATES FISCAL 2026 OUTLOOK
2025, store closing costs, (ii) expenses related to the proxy contest in connection with the Company's 2024 and 2025 annual meeting of shareholders, (iii) expenses associated with the Company's strategic transformation initiative, (iv) a corporate restructuring charge that includes consulting fees related
More news about: Cracker Barrel Old Country Store, Inc.
Mar 04, 2026, 14:10 ET SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--THR, BCO, NATL, and KORE
receive, for each share of Thermon common stock, either: (i) $10.00 in cash and 0.6840 shares of CECO common stock, (ii) $63.89 in cash per share, or (iii) 0.8110 shares of CECO common stock per share.Click here for more information
More news about: Monteverde & Associates PC
Mar 04, 2026, 14:10 ET MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
allowed Ardent Health to report higher amounts of accounts receivable during the Class Period, and delay recognizing losses on uncollectable accounts; (iii) consequently, Ardent Health's reported financial position was materially false and misleading; (iv) Ardent Health did not maintain professional malpractice
More news about: Robbins Geller Rudman & Dowd LLP
Mar 04, 2026, 12:50 ET SIRIUSXM ANNOUNCES PRICING TERMS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING 3.125% SENIOR NOTES DUE 2026
obligations, in such amounts as would be sufficient to pay the principal of and interest on, the Notes to the redemption date or the maturity date, or (iii) pursue any combination of the foregoing. This press release does not constitute a notice of redemption or an offer to purchase the Notes not purchased
More news about: Sirius XM Holdings Inc.
Mar 04, 2026, 11:15 ET BCEN's Critical Care Ground Transport Nursing Specialty Certification Turns 20
BCEN board of directors immediate past chairperson, and senior director of clinical education and critical care clinical nurse specialist at Life Link III. "As patients grow sicker, transport times lengthen, and resources become more limited, ground transport–specific expertise matters more than ever. CTRN
More news about: Board of Certification for Emergency Nursing
Mar 04, 2026, 11:00 ET American Express Expands Global Sports and Entertainment Footprint with New Stadium and NFL Team Partnerships
the 1968 season, the team made history by becoming the first AFL franchise to win a world championship, defeating the Baltimore Colts in Super Bowl III—a victory widely credited with validating the AFL ahead of its 1970 merger with the NFL. Today, as one of the league's flagship franchises in the nation's
More news about: New York Jets